Disorders of blood gases, electrolytes, magnesium, albumin and calcium metabolism in SARS-CoV-2-infected patients
Texila International Journal of Public Health
; 10(1), 2022.
Article
in English
| GIM | ID: covidwho-1856510
ABSTRACT
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infection is characterized by several malfunctions, including severe pulmonary disorders. Other metabolic consequences of SARS-CoV-2-infection have not been clearly defined. The present study assessed the status of blood gases, calcium metabolism, and electrolytes in SARS-CoV-2-infected individuals. One hundred and thirty-four newly diagnosed SARS-CoV-2-infected patients (age ranged 65-82 years) attendingMullingar Regional Hospital, Republic of Ireland, participated in this study. They all had pulmonary disorders, pyrexia, body pains, etc. SARS-CoV-2 was confirmed in all patients using the RT-PCR molecular test method. The data of another 121 plasma samples of apparently normal, non-SARS-CoV-2-infected individuals taken before the emergence of Covid-19 served as controls. Levels of partial pressure of oxygen (pO2), saturated oxygen (SatO2), partial pressure of carbon dioxide (pCO2), and ionized calcium (Ca2+) were determined in all participants using the potentiometric method in RAPIDPOINT 500 Blood Gases System. Plasma vitamin-D was determined by immune enzymatically technique using DXi 800 Access Immunoassay System. Total calcium, phosphate, albumin, magnesium, and electrolytes were determined by the photometric method using Beckman Au680- Chemistry Analyzer. The results showed significantly (p < 0.05) higher levels of pCO2 and HCO3- in COVID-19-patients compared to controls. Significantly(p < 0.05) lower levels of pO2, SatO2, pH, K+, albumin, total-calcium, Ca2+, magnesium, and vitamin-D were observed in COVID-19 patients compared to controls. Corrected calcium, PO4-, Na+, and Cl- levels did not show significant (p>0.05) changes in the COVID-19-patients compared to controls. Abnormal blood gases, acidosis, hypomagnesaemia, hypoalbuminemia, hypovitaminosis D and calcium metabolic disorders could be features of COVID-19-disease.
7440-70-2; 7439-95-4; 124-38-9; 7782-44-7; 7440-09-7; 1406-16-2; 7782-50-5; calcium; magnesium; coronavirus disease 2019; human diseases; viral diseases; blood gases; electrolytes; albumins; clinical aspects; diagnosis; patients; respiratory diseases; fever; pain; carbon dioxide; oxygen; pressure; immunoassay; potassium; pH; vitamin D; chlorine; hypomagnesaemia; hypoalbuminaemia; metabolic disorders; blood plasma; diagnostic techniques; Severe acute respiratory syndrome coronavirus 2; man; Irish Republic; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; British Isles; Western Europe; Europe; European Union Countries; high income countries; OECD Countries; very high Human Development Index countries; oxygen saturation; SARS-CoV-2; viral infections; clinical picture; Eire; lung diseases; pyrexia; hydrogen ion concentration; potential of hydrogen; hypomagnesemia; magnesium deficiency; hypoalbuminemia; metabolic diseases; plasma (blood)
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Language:
English
Journal:
Texila International Journal of Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS